Call Today: (800) 639-7580
Submit your Avandia claim details for a free, no obligation case review
Get Started:
Avandia class action lawsuits are cases in which multiple plaintiffs with similar injuries pool their legal claims and attempt to recover compensation from GlaxoSmithKline, the maker of Avandia medication.
First approved by the FDA in 1999, Avandia is an oral medication used in the treatment of type-2 diabetes – and NOT indicated for treatment of type-1 diabetes. Avandia comes in pill-form and is generally prescribed to be taken in the morning and evening (with or without food).
However, while this medication is able to improve control over blood glucose levels, it has been found to cause a range of severe health complications, including (but not limited to) heart attack, severe allergic reaction and liver dysfunction.
Consequently, it's essential that diabetes patients:
In May 2007, a critical Avandia study published in the medical journal known as Heart suggested that:
Although no national Avandia recall was issued at the time FDA did vote to require GlaxoSmithKline to include black box warnings on Avandia packaging. A number of Avandia class action lawsuits were filed in an effort to compensate patients seriously injured after taking this medication.
When it comes to obtaining an Avandia settlement, injured parties have a choice to file an individual claim or join an already-progressing class action lawsuit. An Avandia class action lawsuit is most appropriate for plaintiffs who:
Injured Avandia patients can get a thorough evaluation of their cases, as well as expert advice regarding the best choices for their situation, during a free initial consultation.
Plaintiffs who choose to be represented by experienced, professional Avandia class action lawyers will benefit from:
For more information about the current Avandia class action lawsuits, contact us today.
A government run diabetes trial was halted 18 months early after a safety analysis revealed an increased risk of death in patients whose blood sugar levels dipped too low.
The 10,000 patient trial was examining the effectiveness of aggressive ...
A new study published in the Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avandia—that is, it carries a significantly increased risk of heart failure, heart attack, and death.
Ob...
At the urging of the Food and Drug Administration, GlaxoSmithKline is adding a new warning to its once-popular diabetes drug Avandia . An increased risk of heart attack will now appear in additio...
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice